|
FY2026
12 months to Jul 25, 2026
|
FY2025
12 months to Jul 26, 2025
|
FY2024
12 months to Jul 27, 2024
|
FY2023
12 months to Jul 29, 2023
|
FY2022
12 months to Jul 30, 2022
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization expense | |||||
| Share-based compensation expense | |||||
| Non-cash pension settlement loss (gain) | |||||
| Deferred taxes | |||||
| Provision to value inventories at LIFO | |||||
| Impairment of assets | |||||
| Gain on sale of assets | |||||
| Changes in assets and liabilities: | |||||
| Merchandise inventories | |||||
| Patronage dividend receivable | |||||
| Accounts payable to Wakefern | |||||
| Accounts payable and accrued expenses | |||||
| Accrued wages and benefits | |||||
| Income taxes receivable and payable | |||||
| Other assets and liabilities | |||||
| Net cash provided by operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||
| Capital expenditures | |||||
| Proceeds from the sale of assets | |||||
| Investment in notes receivable from Wakefern | |||||
| Investment in real estate partnerships | |||||
| Investment in notes receivable related to New Markets Tax Credit financing | |||||
| Maturity of notes receivable from Wakefern | |||||
| Acquisition of lease right-of-use assets | |||||
| Net cash used in investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||
| Proceeds from issuance of long-term debt | |||||
| Debt issuance costs | |||||
| Proceeds from issuance of notes payable to related parties | |||||
| Principal payments of long-term debt | |||||
| Dividends | |||||
| Treasury stock purchases, including shares surrendered for withholding taxes | |||||
| Proceeds from exercise of stock options | |||||
| Excess tax benefit related to share-based compensation | |||||
| Net cash used in financing activities | |||||
| NET INCREASE/(DECREASE) IN CASH AND CASH EQUIVALENTS | |||||
| CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR | |||||
| CASH AND CASH EQUIVALENTS, END OF YEAR | |||||
| SUPPLEMENTAL DISCLOSURES OF CASH PAYMENTS MADE FOR: | |||||
| Interest | |||||
| Income taxes | |||||
| NONCASH SUPPLEMENTAL DISCLOSURES: | |||||
| Investment in Wakefern and increase in notes payable to Wakefern | |||||
| Capital expenditures included in accounts payable and accrued expenses | |||||
Loading...